Central role for aldose reductase pathway in myocardial ischemic injury

FASEB Journal

Volumn 18, Issue 11, 2004, Pages 1192-1199

  Hwang, Yuying C ^a   Kaneko, Michiyo ^a   Bakr, Soliman ^a   Liao, Hui ^a   Lu, Yan ^a   Lewis, Erin R ^a   Yan, Shidu ^a   Ii, Setsuko ^b   Itakura, Mitsuo ^b   Rui, Liu ^d   Skopicki, Hal ^a   Homma, Shunichi ^a   Schmidt, Ann Marie ^a   Oates, Peter J ^c   Szabolcs, Matthias ^a   Ramasamy, Ravichandran ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^d NONE

Author keywords

Cytosolic redox state; Glucose metabolism; Ischemia reperfusion injury

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALDEHYDE REDUCTASE; CREATINE KINASE; DNA; LACTIC ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PALMITIC ACID; PYRUVIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; MOUSE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REPERFUSION INJURY; TRANSGENIC MOUSE; WESTERN BLOTTING;

ADENOSINE TRIPHOSPHATE; ALDEHYDE REDUCTASE; ANIMALS; CORONARY VESSELS; CYTOSOL; ENZYME INHIBITORS; GLUCOSE; GLYCOLYSIS; L-IDITOL 2-DEHYDROGENASE; LIGATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NAD; NIACIN; ORGAN CULTURE TECHNIQUES; OXIDATION-REDUCTION; PALMITIC ACID; RECOMBINANT FUSION PROTEINS; VENTRICULAR FUNCTION, LEFT;

ANIMALIA; MUS MUSCULUS;

EID: 3442890207     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.03-1400com     Document Type: Article

References (39)

1. Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., Van den Enden, M., Kilo, C., and Tilton, R. G. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42, 801-813
2. Busik, J. V., Hootman, S. R., Greenidge, C. A., and Henry, D. N. (1997) Glucose-specific regulation of aldose reductase in Capan-1 human pancreatic duct cells in vitro. J. Clin. Invest. 100, 1685-1692
3. Srivastava, S. K., Ansari, N. H., Hair, G. A., Awasthi, S., and Das, B. (1986) Activation of human etythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase. Metabolism 35, 114-118
4. 2 activation. Metabolism 46, 41-47
5. Harrison, D. H., Bohren, K. M., Ringe, D., Petsko, G. A., and Gabbay, K. H. (1994) An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose-6-phosphate. Biochemistry 33, 2011-2020
6. Bhatnagar, A., Srivastava, S., Wang, L. F., Chandra, A., Ansari, N. H., and Srivastava, S. K. (1999) Cardiac metabolism of enals. Adv. Exp. Med. Biol. 463, 223-229
7. Srivastava, S., Watowich, S. J., Petrash, J. M., Srivastava, S. K., and Bhatnagar, A. (1999) Structural and kinetic determinants of aldehyde reduction by aldose reductase. Biochemistry 38, 42-54
8. Srivastava, S., Chandra, A., Wang, L. F., Seifert, W. E. J., DaGue, B. B., Ansari, N. H., Srivastava, S. K., and Bhatnagar, A. (1998) Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J. Biol. Chem. 273, 10893-10900
9. Kador, P. F., and Kinoshita, J. H. (1985) Role of aldose reductase in the development of diabetes associated complications. Am. J. Med. 79, 8-12
10. Kador, P. F. (1988) The role of aldose reductase in the development of diabetic complications. Med. Res. Rev. 8, 325-352
11. Gabbay, K. H. (1973) The polyol pathway and the complications of diabetes. N. Engl. J. Med. 288, 831-836
12. Kinoshita, J. H., and Nishimura, C. (1988) The involvement of aldose reductase in diabetic complications. Diabetes Metab. Rev. 4, 323-337
13. Greene, D. A., Lattimer, S. A., and Sima, A. A. F. (1987) Sorbitol, phosphoinolitides and sodium-potassium ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316, 599-606
14. Greene, D. A., Sima, A. A. F., Stevens, M. J., Feldman, E. L., Killen, P. D., Henry, D. N., Thomas, T., Dananberg, J., and Lattimer, S. A. (1993) Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage. Diabetes Metab. Rev. 9, 189-217
15. Greene, D. A., Lattimer, S. A., Ulbrecht, J., and Carrol, P. (1988) Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 8, 290-299
16. Ramasamy, R., Gates, P. J., and Schaefer, S. (1997) Aldose reductase inhibition protects diabetic and non-diabetic rat hearts from ischemic injury. Diabetes 46, 292-300
17. Tracey, W. R., Magee, W. V., Ellery, C. A., MacAndrew, J. T., Smith, A. H., Knight, D. R., and Gates, P. J. (2000) Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury. Am. J. Physiol. 279, H1447-H1452
18. Hwang, Y. C., Sato, S., Tsai, J. Y., Bakr, S., Yan, S. D., Gates, P. J., and Ramasamy, R. (2002) Aldose reductase activation is a key component of myocardial response to ischemia. FASEB J. 16, 243-245
19. Nishimura, C., Matsuura, Y., Kokai, Y., Akera, T., Carper, D. A., Lyons, C., and Flynn, T. G. (1990) Cloning and expression of human aldose reductase. J. Biol. Chem. 265, 9788-9792
20. Yamaoka, T., Nishimura, C., Yamashita, K., Itakura, M., Yamada, T., Fujimoto, J., and Kokai, Y. (1995) Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia 38, 255-261
21. Ramasamy, R., Hwang, Y. C., Whang, J., and Bergmann, S. R. (2001) Protection of ischemic hearts by high glucose is mediated by the glucose transporter, GLUT-4. Am. J. Physiol 281, H290-H297
22. Hwang, Y. C., Bakr, S., Ellery, C. R., Gates, P. J., and Ramasamy R. (2003) Sorbitol dehydrogenase: a novel target for adjunctive protection of ischemic myocardium. FASEB J. 17, 2331-2333
23. Trueblood, N. A., Ramasamy, R., Wang, L. F., and Schaefer, S. (2000) Niacin protects the isolated perfused heart from ischemia/reperfusion injury: the role of lactate/proton co-transport. Am. J. Physiol. 279, H764-H77
24. Takuma, S., Suehiro, K., Cardinale, C., Yano, H., Shimizu, J., Mullis-Jansson, S., Sciacca, R., Wang, J., Burkhoff, D., Di Tullio, M. R., et al. (2001) Anesthetic inhibition in ischemic and non-ischemic murine heart: comparison with conscious echo-cardiographic approach for functional assessment. Am. J. Physiol. 280, H2364-H2370
25. Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J. F., Homma, S., Edwards, N. M., and Itescu, S. (2001) Neoangiogenesis of ischemic myocardium by human adult bone marrow-derived angioblasts prevents postinfarction remodeling and improves cardiac function. Nat. Med. 7, 430-436
26. Broderick, T. L., Quinney, H. A., Barker, C. C., and Lopaschuk, G. D. (1993) Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation. Circulation 87, 972-981
27. Bergmeyer, H. U., Bergmeyer, J., and Grabl, M. (1995) Carbohydrates, VI, Metabolites, Verlag Chemie, Boca Raton, FL, pp. 570-587
28. Siegel, T. W., Smith, S. R., Ellery, C. A., Williamson, J. R., and Gates, P. J. (2000) An enzymatic fluorimetric assay for fructose. Anal. Biochem. 280, 329-331
29. Schaefer, S., and Ramasamy, R. (1997) Glycogen utilization and ischemic injury in the isolated rat heart. Cardiovasc. Res. 35, 90-98
30. Tanimoto, T., Maekawa, K., Okada, S., and Yabe-Nishimura, C. (1998) Clinical analysis of aldose reductase for differential diagnosis of the pathogenesis of diabetic complications. Anal. Chim. Acta 365, 285-292
31. Trueblood, N. A., and Ramasamy, R. (1998) Aldose reductase inhibition improves the altered glucose metabolism of isolated diabetic rat hearts. Am. J. Physiol. 275, H75-H83
32. Park, J.-W., Chun, Y.-S., Kim, M.-S., Park, Y.-C., Kwak, S. J., and Park, S. C. (1998) Metabolic modulation of cellular redox potential can improve cardiac recovery from ischemia-reperfusion injury. Int. J. Cardiol. 65, 139-147
33. Ramasamy, R., Trueblood, N. A., and Schaefer, S. (1998) Metabolic effects of aldose reductase inhibition during low-flow ischemia and reperfusion. Am. J. Physiol. 275, H195-H203
34. Stanley, W. C., Lopaschuk, G. D., Hall, J. L., and McCormack, J. G. (1997) Regulation of myocardial carbohydrate metabolism under normal and ischemic conditions. Potential for pharmacological interventions. Cardiovasc. Res. 33, 243-257
35. Taegtmeyer, H., King, L. M., and Jones, B. E. (1998) Energy substrate metabolism, myocardial, ischemia, and targets for pharmacotherapy. Am. J. Cardiol. 82, 54K-60K
36. Ramasamy, R., Liu, H., Gates, P. J., and Schaefer, S. (1999) Attenuation of ischemia induced increases in sodium and calcium by an aldose reductase inhibitor zopolrestat. Cardiovasc. Res. 42, 130-139
37. Obrosova, I. G., Van Huysen, C., Fathallah, L., Cao, X. C., Greene, D. A., and Stevens, M. J. (2002) An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J. 16, 123-125
38. Chung, S. S., Ho, E. C., Lam, K. S., and Chung, S. K. (2003) Contribution of polyol pathway to diabetes-induced oxidative stress. J. Am. Soc. Nephrol. 14 (Suppl. 3), S233-S236
39. Amano, Y., Yamagishi, S., Kato, N., Inagaki, Y, Okamoto, T., Makino, M., Taniko, K., Hirooka, H., Jomori, T., and Takeuchi, M. (2002) Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes. Biochem. Biophys. Res. Commun. 299, 183-188